Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation

Completed

Conditions studied: Amyloidosis

In brief

This study examines the value of stem cell transplantation in managing light chain amyloidisis.

Key facts

Study ID

NCT01606280

Run by

Mayo Clinic

People needed

400

Starts

2011-06-01

Expected to finish

2013-06-01

Last updated by the study team

2014-01-22

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Eligible for Stem cell transplantation less than age 75

You may not qualify if…

• Creatinine > 3.0
• BNP > 10000

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.